2020
DOI: 10.1016/j.repbio.2020.07.013
|View full text |Cite
|
Sign up to set email alerts
|

Investigation of pituitary adenylate cyclase activating polypeptide (PACAP) in human amniotic fluid samples

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2022
2022

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 60 publications
0
1
0
Order By: Relevance
“…In a recent study, amniotic fluid samples were collected between the 15–19th weeks of gestation from volunteering pregnant women undergoing amniocentesis as a prenatal diagnostic tool. Samples were processed to detect PACAP38-LI with radioimmunoassay ( 150 ), revealing PACAP38-LI in each amniotic fluid sample, with an average level of 401 ± 142 fmol/ml. Earlier data showed higher levels of PACAP in maternal serum in late pregnancy ( 33 ) and the increasing content of PACAP in the placenta during pregnancy ( 101 ), indicating its probable placental and/or maternal origin.…”
Section: Human Findingsmentioning
confidence: 99%
“…In a recent study, amniotic fluid samples were collected between the 15–19th weeks of gestation from volunteering pregnant women undergoing amniocentesis as a prenatal diagnostic tool. Samples were processed to detect PACAP38-LI with radioimmunoassay ( 150 ), revealing PACAP38-LI in each amniotic fluid sample, with an average level of 401 ± 142 fmol/ml. Earlier data showed higher levels of PACAP in maternal serum in late pregnancy ( 33 ) and the increasing content of PACAP in the placenta during pregnancy ( 101 ), indicating its probable placental and/or maternal origin.…”
Section: Human Findingsmentioning
confidence: 99%